Article Details
Retrieved on: 2018-03-20 03:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>SAN DIEGO, March 20, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that it intends to offer and sell, subject to market and other conditions, 7,500,000 shares of its common <b>stock</b> in an underwritten public offering. Arena expects to grant the underwriters an option ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here